Imatinib has the potential to exert its antileukemia effects by down-regulating hERG1 K+ channels in chronic myelogenous leukemia.
| Image |  |
|---|---|
| Description | scientific article published on 10 December 2011 |
| Author/s |
author: Yi-Mei Du |
| Publication date | December 10, 2011 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |